Literature DB >> 11173605

Differential Expression of Markers in Extensive and Restricted Langerhans Cell Histiocytosis (LCH).

Ferenc Kôhalmi1, János Strausz, Márta Egerváry, György Szekeres, József Tímár.   

Abstract

Langerhans cell histiocytosis (LCH) represents a poorly defined pathologic entity characterized by diverse clinical appearence and falling into two major categories namely a restricted and an extensive disease. Since the outcome and the course of the disease is variable, we postulated that this might be reflected by the phenotype of the Langerhans cells. We have selected 11 adult restricted cases and 10 extensive childhood cases and compared the phenotype of LCH cells by immunohistochemistry on paraffin sections. Morphometric analysis indicated a significantly higher expression of histiocytic (CD68, S-100, lysozyme) markers in the adult restricted cases compared to the extensive form of the disease. Both groups were equally positive for LCH marker CD1a and negative for T cell marker CD4. On the other hand, HLA-DR expression was significantly higher in LCH cells of the extensive childhood cases suggesting higher activation. These data suggest that LCH cells have a different phenotype in the extensive childhood and restricted adult LCH where the latter is characterized by a more differentiated histiocytic phenotype.

Entities:  

Year:  1996        PMID: 11173605     DOI: 10.1007/bf02903525

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  8 in total

1.  Immunohistochemical study of the abnormal cells in Langerhans cell histiocytosis (histiocytosis x).

Authors:  K Ornvold; E Ralfkiaer; H Carstensen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Immunohistochemical and ultrastructural study of histiocytosis X and non-X histiocytoses.

Authors:  M Fartasch; N Vigneswaran; T L Diepgen; O P Hornstein
Journal:  J Am Acad Dermatol       Date:  1990-11       Impact factor: 11.527

Review 3.  Langerhans cell histiocytosis.

Authors:  R M Egeler; G J D'Angio
Journal:  J Pediatr       Date:  1995-07       Impact factor: 4.406

Review 4.  Langerhans cell histiocytosis.

Authors:  S Belaich
Journal:  Dermatology       Date:  1994       Impact factor: 5.366

5.  Langerhans' cell histiocytosis cells are activated Langerhans' cells.

Authors:  J F Emile; S Fraitag; M Leborgne; Y de Prost; N Brousse
Journal:  J Pathol       Date:  1994-10       Impact factor: 7.996

6.  Immunohistochemical detection of CD1A antigen in formalin-fixed and paraffin-embedded tissue sections with monoclonal antibody 010.

Authors:  L Krenács; L Tiszalvicz; T Krenács; L Boumsell
Journal:  J Pathol       Date:  1993-10       Impact factor: 7.996

7.  Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis.

Authors:  R C Yu; C Chu; L Buluwela; A C Chu
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

8.  Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative disease.

Authors:  C L Willman; L Busque; B B Griffith; B E Favara; K L McClain; M H Duncan; D G Gilliland
Journal:  N Engl J Med       Date:  1994-07-21       Impact factor: 91.245

  8 in total
  1 in total

1.  Differential cell reaction upon Toll-like receptor 4 and 9 activation in human alveolar and lung interstitial macrophages.

Authors:  Jessica Hoppstädter; Britta Diesel; Robert Zarbock; Tanja Breinig; Dominik Monz; Marcus Koch; Andreas Meyerhans; Ludwig Gortner; Claus-Michael Lehr; Hanno Huwer; Alexandra K Kiemer
Journal:  Respir Res       Date:  2010-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.